FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert Castleberry

Research Profile

Disorders

Living Beings

Concepts & Ideas

Procedures

Genes & Molecular Sequences

Genes, myc

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Kimberly F Whelan; Kayla Stratton; Toana Kawashima; John W Waterbor; Robert P Castleberry; Marilyn Stovall; Charles A Sklar; Roger J Packer; Pauline Mitby; Candice L Aitken; Julie Blatt; Leslie L Robison; Ann C Mertens
Ocular late effects in childhood and adolescent cancer survivors: a report from the childhood cancer survivor study.
Jennifer Schneiderman; Wendy B London; Garrett M Brodeur; Robert P Castleberry; A Thomas Look; Susan Cohn
Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology Group.
Sophie Archambeault; Nikki J Flores; Ayami Yoshimi; Christian P Kratz; Miriam Reising; Alexandra Fischer; Peter Noellke; Franco Locatelli; Petr Sedlacek; Christian Flotho; Marco Zecca; Peter D Emanuel; Robert P Castleberry; Charlotte M Niemeyer; Peter Bader; Mignon L Loh
Development of an allele-specific minimal residual disease assay for patients with juvenile myelomonocytic leukemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert Castleberry (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Kimberly F Whelan; Kayla Stratton; Toana Kawashima; John W Waterbor; Robert P Castleberry; Marilyn Stovall; Charles A Sklar; Roger J Packer; Pauline Mitby; Candice L Aitken; Julie Blatt; Leslie L Robison; Ann C Mertens
Ocular late effects in childhood and adolescent cancer survivors: a report from the childhood cancer survivor study.
Pediatric blood & cancer 2010;54(1):103-9.
2008: Jennifer Schneiderman; Wendy B London; Garrett M Brodeur; Robert P Castleberry; A Thomas Look; Susan Cohn
Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(6):913-8.
2008: Sophie Archambeault; Nikki J Flores; Ayami Yoshimi; Christian P Kratz; Miriam Reising; Alexandra Fischer; Peter Noellke; Franco Locatelli; Petr Sedlacek; Christian Flotho; Marco Zecca; Peter D Emanuel; Robert P Castleberry; Charlotte M Niemeyer; Peter Bader; Mignon L Loh
Development of an allele-specific minimal residual disease assay for patients with juvenile myelomonocytic leukemia.
Blood 2008;111(3):1124-7.
2007: Gregory Kane Friedman; Robert P Castleberry
Changing trends of research and treatment in infant neuroblastoma.
Pediatric blood & cancer 2007;49(7 Suppl):1060-5.
2006: Marcio Malogolowkin; Howard M Katzenstein; Mark Krailo; Zhengjia Chen; Laura Bowman; Marleta Reynolds; Milton Finegold; Brian Greffe; Jon Rowland; Kurt Newman; Richard B Womer; Wendy B London; Robert P Castleberry
Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(18):2879-84.
2006: Neyssa M Marina; Wendy B London; Lindsay Frazier; Stephen Lauer; Frederick J Rescorla; Barbara Ann Cushing; Marcio Malogolowkin; Robert P Castleberry; Richard B Womer; Thomas Olson
Prognostic factors in children with extragonadal malignant germ cell tumors: a pediatric intergroup study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(16):2544-8.
2005: Rochelle Bagatell; Pavlina Rumcheva; Wendy B London; Susan Cohn; A Thomas Look; Garrett M Brodeur; Christopher Frantz; Vijay Joshi; Paul Thorner; P V Rao; Robert P Castleberry; Laura C Bowman
Outcomes of children with intermediate-risk neuroblastoma after treatment stratified by MYCN status and tumor cell ploidy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(34):8819-27.
2005: Wendy B London; Luca Boni; Thorsten Simon; Frank Berthold; Clare Twist; Mary Lou Schmidt; Robert P Castleberry; Katherine K Matthay; Susan Cohn; Bruno De Bernardi
The role of age in neuroblastoma risk stratification: the German, Italian, and children's oncology group perspectives.
Cancer letters 2005;228(1-2):257-66.
2005: SM Castellino; Jacqueline Casillas; Melissa M Hudson; Ann C Mertens; John Whitton; Sandra L Brooks; Lonnie K Zeltzer; Arthur Ablin; Robert P Castleberry; Wendy L Hobbie; Sue Kaste; Leslie L Robison; Kevin C Oeffinger
Minority adult survivors of childhood cancer: a comparison of long-term outcomes, health care utilization, and health-related behaviors from the childhood cancer survivor study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6499-507.
2005: Wendy B London; Robert P Castleberry; K K Matthay; A Thomas Look; Robert C Seeger; H Shimada; Paul Thorner; Garrett M Brodeur; John M Maris; Charles Patrick Reynolds; Susan Cohn
Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6459-65.
2005: Rani E George; Wendy B London; Susan Cohn; John M Maris; Cynthia S Kretschmar; Lisa Diller; Garrett M Brodeur; Robert P Castleberry; A Thomas Look
Hyperdiploidy plus nonamplified MYCN confers a favorable prognosis in children 12 to 18 months old with disseminated neuroblastoma: a Pediatric Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6466-73.
2005: Christian P Kratz; Charlotte M Niemeyer; Robert P Castleberry; Mualla Cetin; Eva Bergsträsser; Peter D Emanuel; Henrik Hasle; Gabriela Kardos; Cornelia Klein; Seiji Kojima; Jan Stary; Monika M Trebo; Marco Zecca; Bruce D Gelb; Marco Tartaglia; Mignon L Loh
The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease.
Blood 2005;106(6):2183-5.
2005: Carlos Rodriguez-Galindo; Marcia Wofford; Robert P Castleberry; Gregory Swanson; Wendy B London; James Fontanesi; Alberto S Pappo; Edwin C Douglass
Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinoma.
Cancer 2005;103(4):850-7.
2005: Eric J Gratias; Y Lucy Liu; Sreelatha Meleth; Robert P Castleberry; Peter D Emanuel
Activating FLT3 mutations are rare in children with juvenile myelomonocytic leukemia.
Pediatric blood & cancer 2005;44(2):142-6.
2004: Cynthia S Kretschmar; Morris Kletzel; Kevin Murray; Paul Thorner; Vijay Joshi; Robert Marcus; E Ide Smith; Wendy B London; Robert P Castleberry
Response to paclitaxel, topotecan, and topotecan-cyclophosphamide in children with untreated disseminated neuroblastoma treated in an upfront phase II investigational window: a pediatric oncology group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(20):4119-26.
2004: Barbara Ann Cushing; Roger Giller; John W Cullen; Neyssa M Marina; Stephen Lauer; Thomas A Olson; Paul C Rogers; Paul M Colombani; Frederick J Rescorla; Deborah F Billmire; Charles Vinocur; Edith P Hawkins; Mary Margaret Davis; Elizabeth J. Perlman; Wendy B London; Robert P Castleberry
Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(13):2691-700.
2004: Tara Patton; Andrew F Olshan; Joseph P Neglia; Robert P Castleberry; Joanna Smith
Parental exposure to medical radiation and neuroblastoma in offspring.
Paediatric and perinatal epidemiology 2004;18(3):178-85.
2004: Brad J Zebrack; James G Gurney; Kevin C Oeffinger; John Whitton; Roger J Packer; Ann C Mertens; Norman Turk; Robert P Castleberry; ZoAnn Dreyer; Leslie L Robison; Lonnie K Zeltzer
Psychological outcomes in long-term survivors of childhood brain cancer: a report from the childhood cancer survivor study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(6):999-1006.
2003: John M Maris; Robert P Castleberry
Chemotherapy for neuroblastoma: is it all or none?
Journal of pediatric hematology/oncology 2003;25(7):512-4.
2003: Howard M Katzenstein; Mark Krailo; Marcio Malogolowkin; Jorge A Ortega; Wenchun Qu; Edwin C Douglass; James Feusner; Marleta Reynolds; John J Quinn; Kurt Newman; Milton J Finegold; Joel E Haas; Martha G Sensel; Robert P Castleberry; Laura C Bowman
Fibrolamellar hepatocellular carcinoma in children and adolescents.
Cancer 2003;97(8):2006-12.
2002: Howard M Katzenstein; Mark Krailo; Marcio Malogolowkin; Jorge A Ortega; Wen Liu; Edwin C Douglass; James Feusner; Marleta Reynolds; John J Quinn; Kurt Newman; Milton J Finegold; Joel E Haas; Martha G Sensel; Robert P Castleberry; Laura C Bowman
Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children's Cancer Group intergroup study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(12):2789-97.
2001: Prasad Mathew; Marcus B Valentine; Laura C Bowman; ST Rowe; MB Nash; Virginia Valentine; Susan Cohn; Robert P Castleberry; Garrett M Brodeur; A Thomas Look
Detection of MYCN gene amplification in neuroblastoma by fluorescence in situ hybridization: a pediatric oncology group study.
Neoplasia (New York, N.Y.) 2001;3(2):105-9.
2001: Julie L Daniels; Andrew F Olshan; Kay Teschke; Irva Hertz-Picciotto; David A Savitz; Julie Blatt; Melissa L Bondy; Joseph P Neglia; Bradley Pollock; Susan Cohn; AT Look; Robert C Seeger; Robert P Castleberry
Residential pesticide exposure and neuroblastoma.
Epidemiology (Cambridge, Mass.) 2001;12(1):20-7.
2000: CS Alvarado; Wendy B London; A Thomas Look; Garrett M Brodeur; D H Altmiller; Paul Thorner; Vijay V Joshi; ST Rowe; MB Nash; E Ide Smith; Robert P Castleberry; Susan Cohn
Natural history and biology of stage A neuroblastoma: a Pediatric Oncology Group Study.
Journal of pediatric hematology/oncology 2000;22(3):197-205.
2000: Elizabeth J. Perlman; J Hu; D Ho; Barbara Ann Cushing; Stephen Lauer; Robert P Castleberry
Genetic analysis of childhood endodermal sinus tumors by comparative genomic hybridization.
Journal of pediatric hematology/oncology 2000;22(2):100-5.
2000: Peter D Emanuel; Richard C Snyder; T Wiley; B Gopurala; Robert P Castleberry
Inhibition of juvenile myelomonocytic leukemia cell growth in vitro by farnesyltransferase inhibitors.
Blood 2000;95(2):639-45.
1999: Andrew F Olshan; Anneclaire J De Roos; Kay Teschke; Joseph P Neglia; Daniel O Stram; Bradley Pollock; Robert P Castleberry
Neuroblastoma and parental occupation.
Cancer causes & control : CCC 1999;10(6):539-49.
1999: Andrew F Olshan; Jennifer Smith; M N Cook; Seymour Grufferman; Bradley Pollock; Daniel O Stram; Robert C Seeger; AT Look; Susan Cohn; Robert P Castleberry; Melissa L Bondy
Hormone and fertility drug use and the risk of neuroblastoma: a report from the Children's Cancer Group and the Pediatric Oncology Group.
American journal of epidemiology 1999;150(9):930-8.
1999: Barbara Ann Cushing; Roger Giller; A Ablin; L Cohen; J Cullen; Edith Hawkins; SA Heifetz; Mark Krailo; Stephen Lauer; Neyssa M Marina; P V Rao; Frederick J Rescorla; Charles Vinocur; R M Weetman; Robert P Castleberry
Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children's cancer group.
American journal of obstetrics and gynecology 1999;181(2):353-8.
1999: Hiroyuki Shimada; Inge M Ambros; Louis P Dehner; Jun-ichi Hata; Vijay V Joshi; Borghild Roald; Daniel O Stram; Robert B Gerbing; John N Lukens; Katherine K Matthay; Robert P Castleberry
The International Neuroblastoma Pathology Classification (the Shimada system).
Cancer 1999;86(2):364-72.
1999: Neyssa M Marina; Barbara Ann Cushing; Roger Giller; L Cohen; Stephen Lauer; A Ablin; R Weetman; J Cullen; P Rogers; Charles Vinocur; CJ Stolar; Frederick J Rescorla; Edith Hawkins; SA Heifetz; P V Rao; Mark Krailo; Robert P Castleberry
Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: A Pediatric Oncology Group/Children's Cancer Group Intergroup Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(7):2137-43.
1999: M P Contador; S Johnston; E Ide Smith; J J Shuster; F A Hayes; Robert P Castleberry
Lymph node sampling in localized neuroblastoma: a Pediatric Oncology Group study.
Journal of pediatric surgery 1999;34(6):967-74.
1999: Robert P Castleberry
Consistently investigating the inconsistent nature of neuroblastoma.
Journal of pediatric hematology/oncology 1999;21(3):178-80.
1998: Lucy E Side; Peter D Emanuel; B Taylor; J Franklin; P Thompson; Robert P Castleberry; Kevin Shannon
Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinical evidence of neurofibromatosis, type 1.
Blood 1998;92(1):267-72.
1998: Howard M Katzenstein; Laura C Bowman; Garrett M Brodeur; Paul Thorner; Vijay V Joshi; E Ide Smith; A Thomas Look; ST Rowe; MB Nash; T Holbrook; C Alvarado; P V Rao; Robert P Castleberry; Susan Cohn
Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(6):2007-17.
1998: Robert C Shamberger; E Ide Smith; Vijay V Joshi; P V Rao; F A Hayes; Laura C Bowman; Robert P Castleberry
The risk of nephrectomy during local control in abdominal neuroblastoma.
Journal of pediatric surgery 1998;33(2):161-4.
1997: Douglas R Strother; Jack van Hoff; P V Rao; E Ide Smith; Robert C Shamberger; E C Halperin; K J Murray; Robert P Castleberry
Event-free survival of children with biologically favourable neuroblastoma based on the degree of initial tumour resection: results from the Pediatric Oncology Group.
European journal of cancer (Oxford, England : 1990) 1997;33(12):2121-5.
1997: Robert P Castleberry; J Pritchard; P Ambros; F Berthold; Garrett M Brodeur; V Castel; Susan Cohn; Bruno De Bernardi; C Dicks-Mireaux; D Frappaz; Gerald M Haase; M Haber; D R Jones; Vijay V Joshi; M Kaneko; J T Kemshead; P Kogner; R E Lee; Katherine K Matthay; J M Michon; R Monclair; Borghild Roald; Robert C Seeger; Peter Shaw; J J Shuster
The International Neuroblastoma Risk Groups (INRG): a preliminary report.
European journal of cancer (Oxford, England : 1990) 1997;33(12):2113-6.
1997: Robert P Castleberry
Neuroblastoma.
European journal of cancer (Oxford, England : 1990) 1997;33(9):1430-7; discussion 1437-8.
1997: Robert P Castleberry
Biology and treatment of neuroblastoma.
Pediatric clinics of North America 1997;44(4):919-37.
1997: Laura C Bowman; Robert P Castleberry; A Cantor; Vijay Joshi; Susan Cohn; E Ide Smith; Alice L Yu; Garrett M Brodeur; F A Hayes; A Thomas Look
Genetic staging of unresectable or metastatic neuroblastoma in infants: a Pediatric Oncology Group study.
Journal of the National Cancer Institute 1997;89(5):373-80.
1997: CS Alvarado; Cynthia S Kretschmar; Vijay V Joshi; Stuart Toledano; A Cantor; Douglas R Strother; R Nitschke; Robert P Castleberry
Chemotherapy for patients with recurrent or refractory neuroblastoma: a POG Phase II study.
Journal of pediatric hematology/oncology 1997;19(1):62-7.
1996: Vijay V Joshi; A B Cantor; G Altshuler; L J Cohen; E W Larkin; Jonathan J Shuster; P V Rao; C T Holbrook; F A Hayes; Robert P Castleberry
Conventional versus modified morphologic criteria for ganglioneuroblastoma. A review of cases from the Pediatric Oncology Group.
Archives of pathology & laboratory medicine 1996;120(9):859-65.
1996: Vijay V Joshi; P V Rao; A B Cantor; G Altshuler; Jonathan J Shuster; Robert P Castleberry
Modified histologic grading of neuroblastomas by replacement of mitotic rate with mitosis karyorrhexis index. A clinicopathologic study of 223 cases from the Pediatric Oncology Group.
Cancer 1996;77(8):1582-8.
1995: J A Morris; S J Shcochat; E Ide Smith; A Thomas Look; Garrett M Brodeur; A B Cantor; Robert P Castleberry
Biological variables in thoracic neuroblastoma: a Pediatric Oncology Group study.
Journal of pediatric surgery 1995;30(2):296-302; discussion 302-3.
1994: Robert P Castleberry; Jonathan J Shuster; E Ide Smith
The Pediatric Oncology Group experience with the international staging system criteria for neuroblastoma. Member Institutions of the Pediatric Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(11):2378-81.
1994: Robert P Castleberry; A B Cantor; A A Green; V Joshi; Roger L Berkow; G R Buchanan; B Leventhal; D H Mahoney; E Ide Smith; F A Hayes
Phase II investigational window using carboplatin, iproplatin, ifosfamide, and epirubicin in children with untreated disseminated neuroblastoma: a Pediatric Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(8):1616-20.
1993: G A Adams; S J Shochat; E Ide Smith; J J Shuster; Vijay V Joshi; G Altshuler; F A Hayes; R Nitschke; N McWilliams; Robert P Castleberry
Thoracic neuroblastoma: a Pediatric Oncology Group study.
Journal of pediatric surgery 1993;28(3):372-7; discussion 377-8.
1992: Robert P Castleberry; Jonathan J Shuster; G Altshuler; E Ide Smith; R Nitschke; N Winick; N McWilliams; V Joshi; F A Hayes
Infants with neuroblastoma and regional lymph node metastases have a favorable outlook after limited postoperative chemotherapy: a Pediatric Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(8):1299-304.
1992: Vijay V Joshi; A B Cantor; G Altshuler; E W Larkin; J S Neill; Jonathan J Shuster; C T Holbrook; F A Hayes; Robert P Castleberry
Recommendations for modification of terminology of neuroblastic tumors and prognostic significance of Shimada classification. A clinicopathologic study of 213 cases from the Pediatric Oncology Group.
Cancer 1992;69(8):2183-96.
1991: R Nitschke; E Ide Smith; G Altshuler; D Altmiller; J Shuster; A Green; Robert P Castleberry; F A Hayes; B Golembe; R Ducos
Postoperative treatment of nonmetastatic visible residual neuroblastoma: a Pediatric Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(7):1181-8.
1991: Jonathan J Shuster; A B Cantor; N McWilliams; J G Pole; Robert P Castleberry; R Marcus; T Pick; E Ide Smith; F A Hayes
The prognostic significance of autologous bone marrow transplant in advanced neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(6):1045-9.
1991: Robert P Castleberry; L E Kun; Jonathan J Shuster; G Altshuler; I E Smith; R Nitschke; Moody D Wharam; N McWilliams; V Joshi; F A Hayes
Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(5):789-95.
1991: A Thomas Look; F A Hayes; Jonathan J Shuster; E C Douglass; Robert P Castleberry; Laura C Bowman; E Ide Smith; Garrett M Brodeur
Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(4):581-91.